Skip to main content

Table 1 Patients’ characteristics, surgery, follow-up and mortality

From: One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts

Patients (n) exclusive 3 non-device related deaths 19
Gender (n; male) 16
Age (years; mean ± std; min.-max.) 70.4 ± 9.5 (51–81)
Body weight (kg; mean ± std) 80.1 ± 15.0
Bodymassindex (kg/m2; mean ± std) 28.2 ± 5.3
NYHA / CCS classification (n; %) NYHA CCS
I 13 (68.4 %) 2 (10.5 %)
II 4 (21.1 %) 10 (52.7 %)
III 2 (10.5 %) 5 (26.3 %)
IV 0 2 (10.5 %)
Left ventricular ejection fraction (%; mean ± std) 49 ± 11
CAD in 1° relative (n; %) 17 (89.5 %)
Arterial hypertension (n; %) 18 (94.7 %)
Diabetes (n; %; on insuline/oral antidiabetics/diet) 0 (0 %) / 2 (10.5 %)/6 (31.5 %)
Dyslipidemia (n; %) 16 (84.2 %) + 1 (5.3 %) unknown
Smoking (n; %; current/former/never) 2 (10.5 %)/13 (68.4 %)/4 (21.1 %)
Previous myocardial infarction (n; %) 13 (68.4 %) + 5 (26.3 %) no + 1 (5.3 %) unknown
Previous cerebrovascular event (n; %) 2 (10.5 %) (TIA only)
Previous CABG (n; %) 0 (0 %)
Revascularisation (n;%; OPCAB/ECC/MECC) 11 (57.9 %)/5 (26.3 %)/3 (15.8 %)
Extracorporeal circulation time (min; mean ± std)1) 113.9 ± 35.5 (n = 8)
Cross clamp time (min; mean ± std)1) 79.9 ± 25.3 (n = 8)
Days on intensive care unit (mean ± std) 2.3 ± 1.3
In-hospital days (mean ± std) 10.3 ± 4.7
Directly device-related complications (n) 0
MACCE (n; %) 1 (5.3 %) (Stroke with paraparesis, complete remission)
  1. NYHA: New York Heart Association, CCS: Canadian Cardiovascular Society, CAD: Coronary arterial disease, TIA: Transient ischemic attack, CABG: Coronary artery bypass grafting, OPCAB: Off-pump coronary artery bypass, ECC: Extracorporeal circulation, MECC: Minimal extracorporeal circulation, MACCE: Major adverse cardiac and cerebrovascular event, 1) including concomitant aortic valve replacement